SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-020708
Filing Date
2016-11-03
Accepted
2016-11-03 14:38:07
Documents
59
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aerie93016.htm 10-Q 788218
2 EXHIBIT 31.1 aeri9302016ex311.htm EX-31.1 16397
3 EXHIBIT 31.2 aeri9302016ex312.htm EX-31.2 16500
4 EXHIBIT 32.1 aeri9302016ex321.htm EX-32.1 10026
5 EXHIBIT 32.2 aeri9302016ex322.htm EX-32.2 9974
  Complete submission text file 0001628280-16-020708.txt   4448305

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aeri-20160930.xml EX-101.INS 976481
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20160930.xsd EX-101.SCH 33733
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20160930_cal.xml EX-101.CAL 52890
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20160930_def.xml EX-101.DEF 121503
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20160930_lab.xml EX-101.LAB 447319
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20160930_pre.xml EX-101.PRE 247051
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 161971193
SIC: 2836 Biological Products, (No Diagnostic Substances)